Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Louisiana Blue | 00237 Pharmacogenomic and Metabolite Markers for Patients Treated with Thiopurines- Retired PolicyPayerPolicy · BCBSLA-00237-FB22E2AE0E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00468 Pharmacogenetic Testing for Pain Management- Retired PolicyPayerPolicy · BCBSLA-00468-B706DAB329 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00473 Implantable Peripheral Nerve Stimulation DevicesPayerPolicy · BCBSLA-00473-3E8D580DD4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00094 Vertebroplasty/Kyphoplasty-Retired PolicyPayerPolicy · BCBSLA-00094-EDB43A1D38 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00296 Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial FibrillationPayerPolicy · BCBSLA-00296-115F873791 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00077 Electrothermal Annuloplasty, Radiofrequency Annuloplasty and BiacuplastyPayerPolicy · BCBSLA-00077-1229F13A95 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00208 Automated Percutaneous and Percutaneous Endoscopic DiscectomyPayerPolicy · BCBSLA-00208-0058DE03D4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00531 penicillamine (Cuprimine)/trientine(Syprine, Cuvrior), genericsPayerPolicy · BCBSLA-00531-7104B0FB11 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00375 Pegylated Interferons (Pegasys, PegIntron) for Other (Non-Hepatitis C) UsesPayerPolicy · BCBSLA-00375-D1DC45FF92 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00290 pegloticase (Krystexxa)PayerPolicy · BCBSLA-00290-51E008DD6B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00334 Molecular Testing for the Management of Pancreatic Cysts or Barrett Esophagus, and Solid Pancreaticobiliary Lesions- Retired PolicyPayerPolicy · BCBSLA-00334-B67C514190 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00384 pasireotide Injection (Signifor/Signifor LAR)PayerPolicy · BCBSLA-00384-CA2EA12EE4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00093 Partial Coherence Interferometry as a Technique to Measure the Axial Length of the Eye -Retired PolicyPayerPolicy · BCBSLA-00093-D5CFE37BD0 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00239 Teriparatide ProductsPayerPolicy · BCBSLA-00239-F3ACDF3AFE | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00357 Overactive Bladder Medications (Branded)PayerPolicy · BCBSLA-00357-E3AC812D49 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00090 Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory ConditionsPayerPolicy · BCBSLA-00090-B67169E9C8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00258 Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitute Products Used With Autologous Bone Marrow) - Retired PolicyPayerPolicy · BCBSLA-00258-10333E889B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00476 Therapeutic use of Stem Cells, Blood and Bone Marrow ProductsPayerPolicy · BCBSLA-00476-F474A752DD | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00521 Oravig (miconazole buccal tablets)PayerPolicy · BCBSLA-00521-74DE2C3431 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00354 Oral Non-Sedating Antihistamines and Singulair Products (Branded)PayerPolicy · BCBSLA-00354-6CA3DDC09B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | OpticalDiagnosticDevicesforEvaluatingSkinLesionsSuspectedofMalignancyArchivedPolicyPayerPolicy · BCBSLA-8CAB4C03-C1B2-4E1A-80DF-1ABF3CCF5988-C8A2924669 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00390 Opioid Antagonists Under Heavy Sedation or General Anesthesia as a Technique of Opioid Detoxification-Retired PolicyPayerPolicy · BCBSLA-00390-32ED94A09A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00363 Select Ophthalmic Prostaglandin-Related AgentsPayerPolicy · BCBSLA-00363-6210E6D049 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00234 Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus-Retired PolicyPayerPolicy · BCBSLA-00234-6B4BC630DB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00336 Lovaza (omega-3-acid ethyl esters capsules)PayerPolicy · BCBSLA-00336-DD39E75DD4 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00222 omalizumab (Xolair)PayerPolicy · BCBSLA-00222-5A024F35D2 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00130 Transcatheter Uterine Artery EmbolizationPayerPolicy · BCBSLA-00130-A4C1B59775 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00253 Occipital Nerve StimulationPayerPolicy · BCBSLA-00253-4C68FA16C8 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00538 Pharmacotherapy for Primary Biliary CholangitisPayerPolicy · BCBSLA-00538-E525C11F08 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00469 Nutrient/Nutritional Panel Testing-Retired PolicyPayerPolicy · BCBSLA-00469-6EE399E88B | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00550 Treatment for Spinal Muscular AtrophyPayerPolicy · BCBSLA-00550-80DE245BCA | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00273 Novel Lipid Risk Factors in Risk Assessment and Management of Cardiovascular Disease - RetiredPayerPolicy · BCBSLA-00273-7C9328B569 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00086 Nonmyeloablative Allogeneic Transplants of Hematopoietic Stem Cells for Treatment of Malignancy - Retired PolicyPayerPolicy · BCBSLA-00086-895133D79F | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00537 Coronary Computed Tomography Angiography With Selective Noninvasive Fractional Flow Reserve-Retired PolicyPayerPolicy · BCBSLA-00537-3AA45629F1 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00400 Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNA - Retired PolicyPayerPolicy · BCBSLA-00400-63BC45798D | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | Neuromuscular Electrical Stimulation (NMES) for Muscle Rehabilitation - Retired policyPayerPolicy · BCBSLA-484D9C2D-3183-4143-A78E-12FF87C7D98C-F0ED6F5622 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00186 NeurodiagnosticsPayerPolicy · BCBSLA-00186-22F10C321E | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00085 nesiritide (Natrecor) - Retired PolicyPayerPolicy · BCBSLA-00085-B119EBA43C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00113 Nerve Graft With Radical Prostatectomy- Retired PolicyPayerPolicy · BCBSLA-00113-34806E8EE9 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00240 Nerve Fiber Density Testing - Retired PolicyPayerPolicy · BCBSLA-00240-531C226B82 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00407 Navigated Transcranial Magnetic Stimulation-Retired PolicyPayerPolicy · BCBSLA-00407-79F6B03447 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00156 natalizumab ProductsPayerPolicy · BCBSLA-00156-1ACE610759 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00443 Myoelectric Prosthetic and Orthotic Components for the Upper LimbPayerPolicy · BCBSLA-00443-6991F7B143 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00498 Multispectral Digital Skin Lesion Analysis and Reflectance Confocal MicroscopyPayerPolicy · BCBSLA-00498-482E5BD4C3 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00418 Multianalyte Assays with Algorithmic Analyses for Predicting Risk of Type 2 DiabetesPayerPolicy · BCBSLA-00418-9E0B9E3FAB | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00150 Monitoring of Regional Cerebral Blood Flow Using an Implanted Cerebral Thermal Perfusion Probe - Retired PolicyPayerPolicy · BCBSLA-00150-E62A3B513A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00504 Germline Genetic Testing for Gene Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk (CHEK2, ATM, and BARD1)- Retired PolicyPayerPolicy · BCBSLA-00504-3064010F6A | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00361 modafinil (Provigil)/armodafinil (Nuvigil)-Retired PolicyPayerPolicy · BCBSLA-00361-93C2A6ED8C | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00349 mipomersen (Kynamro)-Retired PolicyPayerPolicy · BCBSLA-00349-7D3BC2DC62 | New policy |
|---|
| Aug 2, 2026 | Louisiana Blue | 00547 miltefosine (Impavido)PayerPolicy · BCBSLA-00547-DCDE0075C7 | New policy |
|---|